News

SeekIn has announced the clinical validation of its SeekInCare blood test, intended for the early identification of various ...
Mr George Nita, a General Surgery Registrar and doctoral candidate in Bioinformatics at the University of Liverpool, is ...
Lucknow's walls have become the latest battleground in Uttar Pradesh's political rivalry, with BJP's Minority Morcha ...
Dr. Kristen Scarpato explains the role of genetic testing in prostate cancer care, as well as its use in determining ...
Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...
People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid unnecessary biopsies, officials have announced. About 15,000 patients a year are ...
A groundbreaking study published in the Journal of Molecular Diagnostics reports the successful clinical validation of SeekInCare ®, a novel, non-invasive multi-omics blood test designed for the early ...
Dana-Farber Cancer Institute investigators launch a first-of-its kind study to use a novel blood test to identify people who ...
NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...
Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...